Search
for

    Sort by

    Research 31–60 of 1000+

    1. Urological Oncology: Prostate Cancer 2010
    2. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review European Urology · 2023 · 710 citations
    3. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study Cancer Causes & Control · 2017 · 4 citations
    4. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    5. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    6. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    7. Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007
    8. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    9. 1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY The Journal of Urology · 2012
    10. Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model European Urology Focus · 2026
    11. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    12. Prostate Carcinoma, what would be the best to do ? International Journal of Clinical and Medical Education Research · 2023
    13. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    14. Bernstein’s Consent and Information on Finasteride and Propecia® Hair transplant forum international · 2016
    15. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    16. Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review Journal of Education Health and Sport · 2025
    17. News in brief Expert Review of Endocrinology & Metabolism · 2011
    18. Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men Cancer Epidemiology, Biomarkers & Prevention · 2014 · 9 citations
    19. Significance of the polyglutamine tract polymorphism in the androgen receptor Urology · 2001 · 54 citations
    20. Targeted delivery of siRNA to human cancer and human embryonic stem cells with cell level resolution Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 2016
    21. New Selenoderivatives as Antitumoral Agents InTech eBooks · 2011
    22. This Week in JAMA JAMA · 2009
    23. Effect of Low-Dose Finasteride on Serum PSA Concentrations Journal watch · 2007
    24. Prostatakarzinom Der Urologe · 2011
    25. Screening: seeking a balance Lancet Oncology · 2006
    26. Highlights of This Issue Cancer Epidemiology Biomarkers & Prevention · 2011
    27. Finasteride Doesn't Shorten Survival in Long-term Study Cancer Discovery · 2013
    28. Keeping Our Eye on the Ball: The American Society of Preventive Oncology in 2009 Cancer Epidemiology Biomarkers & Prevention · 2009 · 1 citations
    29. Sometimes Marketing Efforts by Advocacy Organizations Can Lose Touch with the Nuances of Appropriateness Oncology Times · 2004
    30. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006